Lansoprazole
Product Images NDC 50090-4596

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-4596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula Structure (Lansoprazole Delayed Release Capsules 1)

Formula Structure (Lansoprazole Delayed Release Capsules 1)
Chemical structure of lansoprazole, showing its molecular framework including a benzimidazole ring, a sulfinyl group, and a substituted pyridine ring with trifluoromethoxy and methyl groups.*
FDA Label Image

Figure 1 (Lansoprazole Delayed Release Capsules 2)

Figure 1 (Lansoprazole Delayed Release Capsules 2)
A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' showing mean severity scores (0 to 3) on the y-axis and days from start of treatment (-5 to 60) on the x-axis. It compares heartburn severity over time among placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups, with severity decreasing more significantly in Lansoprazole groups compared to placebo.*
FDA Label Image

Figure 2 (Lansoprazole Delayed Release Capsules 3)

Figure 2 (Lansoprazole Delayed Release Capsules 3)
A line graph showing the mean severity of night heartburn over time by study day for evaluable patients. The y-axis represents mean severity from 0 (none) to 3 (severe), and the x-axis represents days from the start of treatment, ranging from -5 to 60 days. Three lines compare placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, with severity generally decreasing over time for both Lansoprazole doses compared to placebo.*
FDA Label Image

Label Image (Lbl500904596)

Label Image (Lbl500904596)
Lansoprazole 15 mg delayed release capsules in a white and purple capsule form. The label shows Product No. 6469-0 and includes storage instructions to keep between 68 to 77 degrees Fahrenheit. It is distributed by A-S Medication Solutions, Lakeville, IL 60044. The packaging indicates a quantity of 30 capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.